|
Canada-0-LaboratoriesTesting شركة الأدلة
|
شركة أخبار :
- Parkinsons disease research in Morocco: a review - PubMed
This work aims to quantify the studies conducted by Moroccan academics on Parkinson's disease (PD), which is a neurological condition that causes shaking, muscle stiffness and slows movement
- Parkinsons Disease Research on the African Continent: Obstacles and . . .
In this Perspective article, we review some of the obstacles that are limiting research and creating barriers for future studies We summarize what research is being done in four sub-Saharan
- Parkinsons disease: From bench to bedside - PubMed
The aim of the current report is to review the latest advances in the understanding of PD etiologies, diagnosis, epidemiology and an overview of the earlier and latest advances in the management of PD, from L-DOPA to adult astroglia reprogramming into dopaminergic neurons in vivo
- Parkinson’s Disease in the Middle East, North Africa, and South Asia . . .
Understanding the regional needs and available healthcare resources to treat Parkinson’s disease (PD) is essential to plan appropriate future priorities
- Marino, B. L. B. , de Souza, L. R. , Sousa, K. P. A. , Ferreira, J. V. , Padilha . . .
ABSTRACT: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by motor symptoms such as tremors, rigidity, and bradykinesia, as well as non-motor symptoms including cognitive impairment and mood disorders
- Parkinson’s Disease: An update on Pathophysiology, Epidemiology . . .
Epidemiology condition (Dorsey et al , 2005) The estimated prevalence of PD in the general population in developed countries is 0 3 percent Parkinson’s disease usually progresses from age 55 to age 65 The prevalence is 1 0 percent for people over the age of 60 and 3 0 percent for pe
- Parkinsons Disease: Vol 2020, No 1 - Wiley Online Library
Enhancement of Executive Functions but Not Memory by Multidomain Group Cognitive Training in Patients with Parkinson’s Disease and Mild Cognitive Impairment: A Multicenter Randomized Controlled Trial
- Recent Advances in Parkinson’s Disease Research: From Pathophysiology . . .
Understanding the multifaceted pathophysiological mechanisms underlying PD is crucial for developing disease-modifying therapeutics and improving clinical outcomes
- Update on the diagnosis and management of Parkinsons disease
Parkinson’s disease (PD) is diagnosed where bradykinesia occurs together with rigidity or tremor, in the presence of supporting features The diagnosis is clinical, and attention should be paid to exclusion criteria indicating an alternative diagnosis and to ‘red flag’ features
- Diagnosis and Treatment of Parkinson Disease: A Review
For all patients with Parkinson disease, treatment is symptomatic, focused on improvement in motor (eg, tremor, rigidity, bradykinesia) and nonmotor (eg, constipation, cognition, mood, sleep) signs and symptoms
|
|